GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NextCell Pharma AB (OSTO:NXTCL) » Definitions » Market Cap

NextCell Pharma AB (OSTO:NXTCL) Market Cap : kr49.34 Mil (As of May. 23, 2024)


View and export this data going back to 2017. Start your Free Trial

What is NextCell Pharma AB Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). NextCell Pharma AB's share price for the quarter that ended in Feb. 2024 was kr2.67. NextCell Pharma AB's Shares Outstanding (EOP) for the quarter that ended in Feb. 2024 was 34.38 Mil. Therefore, NextCell Pharma AB's market cap for the quarter that ended in Feb. 2024 was kr91.79 Mil.

NextCell Pharma AB's quarterly market cap declined from Aug. 2023 (kr123.77 Mil) to Nov. 2023 (kr107.26 Mil) and declined from Nov. 2023 (kr107.26 Mil) to Feb. 2024 (kr91.79 Mil).

NextCell Pharma AB's annual market cap declined from Aug. 2021 (kr498.50 Mil) to Aug. 2022 (kr218.31 Mil) and declined from Aug. 2022 (kr218.31 Mil) to Aug. 2023 (kr123.77 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. NextCell Pharma AB's Enterprise Value for Today is kr18.94 Mil.


NextCell Pharma AB Market Cap Historical Data

The historical data trend for NextCell Pharma AB's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NextCell Pharma AB Market Cap Chart

NextCell Pharma AB Annual Data
Trend Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23
Market Cap
Get a 7-Day Free Trial Premium Member Only 105.37 246.85 498.50 218.31 123.77

NextCell Pharma AB Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 237.22 163.99 123.77 107.26 91.79

Competitive Comparison of NextCell Pharma AB's Market Cap

For the Biotechnology subindustry, NextCell Pharma AB's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NextCell Pharma AB's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, NextCell Pharma AB's Market Cap distribution charts can be found below:

* The bar in red indicates where NextCell Pharma AB's Market Cap falls into.



NextCell Pharma AB Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

NextCell Pharma AB's Market Cap for the fiscal year that ended in Aug. 2023 is calculated as

Market Cap (A: Aug. 2023 )=Share Price (A: Aug. 2023 )*Shares Outstanding (EOP) (A: Aug. 2023 )
=kr3.6*34.3795
=kr123.77

NextCell Pharma AB's Market Cap for the quarter that ended in Feb. 2024 is calculated as

Market Cap (Q: Feb. 2024 )=Share Price (Q: Feb. 2024 )*Shares Outstanding (EOP) (Q: Feb. 2024 )
=kr2.67*34.3795
=kr91.79

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


NextCell Pharma AB  (OSTO:NXTCL) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


NextCell Pharma AB Market Cap Related Terms

Thank you for viewing the detailed overview of NextCell Pharma AB's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


NextCell Pharma AB (OSTO:NXTCL) Business Description

Traded in Other Exchanges
Address
Karolinska Institutet Science Park, Halsovagen 7, Huddinge, SWE, 14157
NextCell Pharma AB is a healthcare services provider. The company is engaged in the research of stem cell and is developing the candidate drug ProTrans for the treatment of diabetes and immunosuppression in kidney transplants.

NextCell Pharma AB (OSTO:NXTCL) Headlines

No Headlines